Human chorionic gonadotropin attenuates amyloid-β plaques induced by streptozotocin in the rat brain by affecting cytochrome c-ir neuron density

Document Type: Original Article


1 Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran

2 Neuroscience Research Center, Department of Anatomy, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran

3 Stem Cell Research Center, Department of Immunology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran


Objective(s): Amyloid β plaques, in Alzheimer’s disease, are deposits in different areas of the brain such as prefrontal cortex, molecular layer of the cerebellum, and the hippocampal formation. Amyloid β aggregates lead to the release of cytochrome c and finally neuronal cell death in brain tissue. hCG has critical roles in brain development, neuron differentiation, and function. Therefore, we investigated the effect of hCG on the density of the congophilic Aβ plaque and cytochrome c-ir neurons in the hippocampus, prefrontal cortex, and cerebellum of Streptozotocin (STZ)-treated rats.
Materials and Methods: Alzheimer model in rats (except the control group) was induced by streptozotocin (3 mg/kg, Intracerebroventricularly (ICV)). Experimental group rats received streptozotocin and then different doses of hCG (50, 100, and 200 IU, intraperitoneally) for 3 days. 48 hr after last drug injection and after histological processing, the brain sections were stained by congo red for congophilic amyloid β plaques and cytochrome c in the hippocampus, prefrontal cortex, and cerebellum were immunohistochemically stained.
Results: Density of congophilic Aβ plaques and cytochrome c-immunoreactive neurons was significantly higher in ICV STZ treated rats than controls. Treatment with three doses of hCG significantly decreased the density of congophilic Aβ plaques and cytochrome c-immunoreactive neurons in the rat hippocampus, prefrontal cortex, and cerebellum in ICV STZ-treated rats (P<0.05).
Conclusion: hCG can be useful in AD patients to prevent the congophilic Aβ plaque formation and decrease cytochrome c-immunoreactive neuron density in the brain.


Main Subjects

1. Guo XD, Sun GL, Zhou TT, Xu X, Zhu ZY, Rukachaisirikul V, et al. Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance. Acta Pharmacol Sin 2016; 37:1281–1297.
2. Comes G, Manso Y, Escrig A, Fernandez-Gayol O, Sanchis P, Molinero A, et al. Influence of transgenic metallothionein-1 on gliosis, CA1 neuronal loss, and brain metal levels of the Tg2576 mouse model of Alzheimer’s disease. Int J Mol Sci 2017; 18:251.
3. Islam MA, Khandker SS, Alam F, Khalil MI, Kamal MA, Gan SH. Alzheimer’s disease and natural products: future regimens emerging from nature. Curr Top Med Chem 2017; 17:1408-1428.
4. Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A. Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: Pathogenesis and treatment. CNS Neurosci Ther 2017; 23:5-22.
5. Cardoso S, Carvalho C, Correia SC, Seiça RM, Moreira PI. Alzheimer’s disease: From mitochondrial perturbations to mitochondrial medicine. Brain Pathol 2016; 26:632-647.
6. Thomann PA, Schläfer C, Seidl U, Dos Santos V, Essig M, Schröder J. The cerebellum in mild cognitive impairment and Alzheimer’s disease–a structural MRI study. J Psychiatr Res 2008; 42:1198-1202.
7. Mavroudis IA, Fotiou DF, Adipepe LF, Manani MG, Njau SD, Psaroulis D, et al. Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer’s disease. Am J Alzheimers Dis Other Demen 2010; 25:585-591.
8. Venkateshappa C, Harish G, Mahadevan A, Bharath MS, Shankar SK. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer’s disease. Neurochem Res 2012; 37:1601-1614.
9. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011; 1:a006189.
10. Arendt T. Synaptic degeneration in Alzheimer’s disease. Acta Neuropathol 2009; 118:167-179.
11. Han SH, Park JC, Mook-Jung I. Amyloid β-interacting partners in Alzheimer’s disease: From accomplices to possible therapeutic targets. Prog Neurobiol 2016; 137:17-38.
12. Wang Y, Cai B, Shao J, Wang TT, Cai RZ, Ma CJ, et al. Genistein suppresses the mitochondrial apoptotic pathway in hippocampal neurons in rats with Alzheimer’s disease. Neural Regen Res 2016; 11:1153–1158.
13. Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer’s disease. Hum Mol Genet 2011; 20:4515-4529.
14. Carvalho C, Correia SC, Perry G, Castellani RJ, Moreira PI. Cerebrovascular and mitochondrial abnormalities in Alzheimer’s disease: A brief overview. J Neural Transm (Vienna) 2016; 123:107-111.
15. Kerr JS, Adriaanse BA, Greig NH, Mattson MP, Cader MZ, Bohr VA, et al. Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms. Trends Neurosci 2017; 40:151-166.
16. Sodhi RK, Singh N. All-trans retinoic acid rescues memory deficits and neuropathological changes in mouse model of streptozotocin-induced dementia of Alzheimer’s type. Prog Neuropsychopharmacol Biol Psychiatry 2013; 40:38-46.
17. Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS. Streptozotocin intracerebroventricular-induced neurotoxicity and brain insulin resistance: A therapeutic intervention for treatment of sporadic Alzheimer’s disease (sAD)-like pathology. Mol Neurobiol 2016; 53:4548-4562.
18. Souza LC, Jesse CR, de Gomes MG, Viana CE, Mattos E, Silva NC, et al. Intracerebroventricular administration of streptozotocin as an experimental approach to depression: Evidence for the involvement of proinflammatory cytokines and indoleamine-2, 3-dioxygenase. Neurotox Res 2017; 31:464-477.
19. Lin Y, Kardos J, Imai M, Ikenoue T, Kinoshita M, Sugiki T, et al. Amorphous aggregation of cytochrome c with inherently low amyloidogenicity is characterized by the metastability of supersaturation and the phase diagram. Langmuir 2016; 32:2010-2022.
20. Kunal SB, Killivalavan A, Medhamurthy R. Involvement of Src family of kinases and cAMP phosphodiesterase in the luteinizing hormone/chorionic gonadotropin receptor-mediated signaling in the corpus luteum of monkey. Reprod Biol Endocrinol 2012; 10:25.
21. Meethal SV, Smith MA, Bowen RL, Atwood CS. The gonadotropin connection in Alzheimer’s disease. Endocrine 2005; 26:317-326.
22. Surico D, Farruggio S, Marotta P, Raina G, Mary D, Surico N, et al. Human chorionic gonadotropin protects vascular endothelial cells from oxidative stress by apoptosis inhibition, cell survival signalling activation and mitochondrial function protection. Cell Physiol Biochem 2015; 36:2108-2120.
23. Berry A, Tomidokoro Y, Ghiso J, Thornton J. Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-β levels in female rats. Horm Behav 2008; 54:143-152.
24. Barron AM, Verdile G, Taddei K, Bates KA, Martins RN. Effect of chronic hCG administration on Alzheimer’s-related cognition and Aβ accumulation in PS1KI mice. Endocrinology 2010; 151:5380-5388.
25. Casadesus G, Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, et al. Luteinizing hormone modulates cognition and amyloid-β deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta 2006; 1762:447-452.
26. Paxinos G, Watson C. The rat brain in stereotaxic coordinates: San Diego: Academic Press; 2007.
27. Moghadami S, Jahanshahi M, Sepehri H, Amini H. Gonadectomy reduces the density of androgen receptor-immunoreactive neurons in male rat’s hippocampus: testosterone replacement compensates it. Behav Brain Funct 2016; 12:5-14.
28. Jahanshahi M, Nikmahzar E, Elyasi L, Babakordi F, Hooshmand E. α2-Adrenoceptor-ir neurons’ density changes after single dose of clonidine and yohimbine administration in the hippocampus of male rat. Int J Neurosci 2018; 128:404-411.
29. Weerateerangkull P, Praputpittaya C, Banjerdpongchai R. Effects of Ascorbic acid on streptozotocin-induced oxidative stress and memory impairment in rats. Thai J Physiol Sci 2008; 20:54-61.
30. Lukacs H, Hiatt E, Lei Z, Rao CV. Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm Behav 1995; 29:42-58.
31. Jahanshahi M, Nickmahzar E, Babakordi F. The effect of Ginkgo biloba extract on scopolamine-induced apoptosis in the hippocampus of rats. Anat Sci Int 2013; 88:217-222.
32. Wilcock DM, Gordon MN, Morgan D. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat Protoc 2006; 1:1591-1595.
33. Kumar A, Singh N. Calcineurin inhibitors improve memory loss and neuropathological changes in mouse model of dementia. Pharmacol Biochem Behav 2017; 153:147-159.
34. Palkovits M, Šebeková K, Klenovics KS, Kebis A, Fazeli G, Bahner U, et al. Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine. PloS One 2013; 8:e66543.
35. Jahanshahi M, Sadeghi Y, Hosseini A. Estimation of astrocyte number in different subfield of rat hippocampus. Pak J Biol Sci 2006; 9:1595-1597.
36. Seifhosseini S, Jahanshahi M, Moghimi A, Aazami N-S. The effect of scopolamine on avoidance memory and hippocampal neurons in male Wistar rats. Basic Clin Neurosci 2011; 3:9-15.
37. Kusbeci OY, Bas O, Gocmen-Mas N, Karabekir HS, Yucel A, Ertekin T, et al. Evaluation of cerebellar asymmetry in Alzheimer’s disease: a stereological study. Dement Geriatr Cogn Disord 2009; 28:1-5.
38. Chen J, Cohen ML, Lerner AJ, Yang Y, Herrup K. DNA damage and cell cycle events implicate cerebellar dentate nucleus neurons as targets of Alzheimer’s disease. Mol Neurodegener 2010; 5:60.
39. Jahanshahi M, Sadeghi Y, Hosseini A, Naghdi N, Golalipour MJ. Astrocytes in Molecular Layer of Cerebellum after Spatial Learning. Basic Clin Neurosci 2012; 3:16-21.
40. Li M, Chen L, Lee DHS, Yu LC, Zhang Y. The role of intracellular amyloid β in Alzheimer’s disease. Prog Neurobiol 2007; 83:131-139.
41. Knezovic A, Osmanovic-Barilar J, Curlin M, Hof PR, Simic G, Riederer P, et al. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer’s disease. J Neural Transm (Vienna) 2015; 122:577-592.
42. Ravelli KG, dos Anjos Rosário B, Camarini R, Hernandes MS, Britto LR. Intracerebroventricular streptozotocin as a model of Alzheimer’s disease: Neurochemical and behavioral characterization in mice. Neurotox Res 2017; 31:327-333.
43. Salkovic-Petrisic M, Osmanovic-Barilar J, Brückner MK, Hoyer S, Arendt T, Riederer P. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study. J Neural Transm (Vienna) 2011; 118:765-772.
44. Correia SC, Santos RX, Santos MS, Casadesus G, LaManna JC, Perry G, et al. Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer’s disease. Curr Alzheimer Res 2013; 10:406-419.
45. Saberi S, Du YP, Christie M, Goldsbury C. Human chorionic gonadotropin increases β-cleavage of amyloid precursor protein in SH-SY5Y cells. Cell Mol Neurobiol 2013; 33:747-751.
46. Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, et al. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-β precursor protein and amyloid-β deposition. J Biol Chem 2004; 279:20539-20545.
47. Porayette P, Gallego MJ, Kaltcheva MM, Meethal SV, Atwood CS. Amyloid-β precursor protein expression and modulation in human embryonic stem cells: A novel role for human chorionic gonadotropin. Biochem Biophys Res Commun 2007; 364:522-527.
48. Lin J, Li X, Yuan F, Lin L, Cook CL, Rao CV, et al. Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol 2010; 69:253-261.
49. Tan JW, Kim MK. Neuroprotective effects of Biochanin A against β-amyloid-induced neurotoxicity in PC12 cells via a mitochondrial-dependent apoptosis pathway. Molecules 2016; 21:548.
50. Bras M, Queenan B, Susin SA. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Moscow) 2005; 70:231-239.
51. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000; 80:315-360.
52. Koo JH, Kang EB, Oh YS, Yang DS, Cho JY. Treadmill exercise decreases amyloid-β burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer’s disease. Exp Neurol 2017; 288:142-152.
53. Genrikhs EE, Stelmashook EV, Golyshev SA, Aleksandrova OP, Isaev NK. Streptozotocin causes neurotoxic effect in cultured cerebellar granule neurons. Brain Res Bull 2017; 130:90-94.
54. Biswas J, Goswami P, Gupta S, Joshi N, Nath C, Singh S. Streptozotocin induced neurotoxicity involves Alzheimer’s related pathological markers: A study on N2A cells. Mol Neurobiol 2016; 53:2794-2806.
55. Wang Y, Miao Y, Mir AZ, Cheng L, Wang L, Zhao L, et al. Inhibition of beta-amyloid-induced neurotoxicity by pinocembrin through Nrf2/HO-1 pathway in SH-SY5Y cells. J Neurol Sci 2016; 368:223-230.
56. An HM, Lin C, Gu C, Chen JJ, Sun WX, Jin M, et al. Di-Huang-Yi-Zhi herbal formula attenuates amyloid-β-induced neurotoxicity in PC12 cells. Exp Ther Med 2017; 13:3003-3008.
57. Wang X, Su B, Perry G, Smith MA, Zhu X. Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease. Free Radic Biol Med 2007; 43:1569-1573.
58. Yankner BA, Lu T. Amyloid β-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 2009; 284:4755-4759.
59. Kuroda H, Mandai M, Konishi I, Tsuruta Y, Kusakari T, Kariya M, et al. Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and HCG inhibits apoptosis of OSE cells via up‐regulation of insulin‐like growth factor‐1. Int J Cancer 2001; 91:309-315.
60. Belayev L, Khoutorova L, Zhao KL, Davidoff AW, Moore AF, Cramer SC. A novel neurotrophic therapeutic strategy for experimental stroke. Brain Res 2009; 1280:117-123.
61. Edmondson RJ, Monaghan JM, Davies BR. Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium. Int J Gynecol Cancer 2006; 16:171-177.
62. Elzarrad K, Haroon A, Reed D, Al-Mehdi AB. Early incorporated endothelial cells as origin of metastatic tumor vasculogenesis. Clin Exp Metastasis 2009; 26:589-598.